Effect of methyldopa on the neurogenic component of the arterial blood pressure.
D000284:Administration, Oral; D000818:Animals; D001338:Autonomic Fibers, Postganglionic / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects*; D003864:Depression, Chemical; D004246:Dimethylphenylpiperazinium Iodide / Q000008:administration & dosage / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D005260:Female; D006584:Hexamethonium Compounds / Q000008:administration & dosage / Q000494:pharmacology; D007275:Injections, Intravenous; D008297:Male; D008750:Methyldopa / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D009435:Synaptic Transmission / Q000187:drug effects; D013997:Time Factors
D006584:Hexamethonium Compounds; D004246:Dimethylphenylpiperazinium Iodide; D008750:Methyldopa; D012110:Reserpine